BrilliA Inc (BRIA) is a Singapore-based provider of women's intimate apparel and lingerie, listed on the NYSE American. Because institutional analyst coverage is extremely limited, this analysis relies on a fallback objective drawn from publicly reported data rather than a calculated consensus. Initiation coverage on August 29, 2025 produced $5.00 price targets from Alliance Global Partners (analyst Aaron Grey, Buy), iA Financial, and a Buy rating from Citigroup. Those figures are now more than a year old and predate a substantial decline in the share price, so they are treated as stale. The only current, widely reported objective is a single $2.75 target with a Strong Buy rating, cited by Yahoo Finance, MSN Money, and Investing.com, and broadly consistent with the $2.78–$2.89 range referenced by Nasdaq/Fintel. With fewer than two verifiable current targets, no meaningful consensus exists, and $2.75 is used here as a publicly discussed objective.
BRIA last traded near $1.32, giving it a market capitalization of roughly $33–40 million. Reaching $2.75 from that level requires an approximate 108% advance — a very large move by any standard, though one consistent with the volatility already seen in a name whose 52-week range spans $1.07 to $2.30 and whose all-time high was about $4.95 shortly after its November 2024 IPO. The company generates trailing revenue of about $49 million and is roughly at breakeven on a net-income basis. A path toward higher prices would likely depend on sustained revenue growth, margin improvement, and successful integration of recent acquisitions.
BRIA's 50-day moving average sits near $1.40, placing the current price below that short-term reference. The 52-week range of $1.07 to $2.30 frames a durable context: the $1.07 low represents major support, while $2.30 marks the most recent cycle high and a meaningful resistance zone. The $2.75 objective sits above that 52-week high, so reaching it would require a breakout beyond the prior trading range.
Analyst price targets conventionally reflect a roughly 12-month horizon, though no specific horizon has been published for the single $2.75 figure. Investors should watch quarterly results and guidance, progress on the Neubodi integration and Jockey Indonesia rollout, any new analyst initiation or target revision, and changes in share count or capital-raising activity. As a micro-cap, headline-driven moves and low-volume swings are also important to monitor. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Can BrilliA (BRIA) stock reach $2.75? The objective is grounded in a single current analyst price target rather than a broad consensus, and it implies a roughly 108% advance from the latest price near $1.32 — a very large move. Supportive factors include revenue scale, recent brand and geographic expansion, and near-breakeven results, while thin liquidity, execution risk, and a lack of multiple independent analyst endorsements represent the principal obstacles. With prior $5.00 targets now stale and current coverage limited to essentially one figure, the $2.75 level should be read as a directional reference rather than a firm forecast. What matters next is whether revenue growth and integration progress can translate into a durable re-rating. From what I see, this remains a name where patience and close monitoring of execution will be key.
I have found Tickeron's AI Daily Buy/Sell Signals helpful for monitoring names like this one where traditional coverage is limited. The tool applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical behavior and market shifts. For thinly traded micro-caps, these signals can surface opportunities and trend changes more efficiently than manual checks alone, offering a practical way to stay on top of developments without relying solely on sparse analyst notes.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
BRIA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 20 of 21 cases where BRIA's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
Following a +3.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where BRIA advanced for three days, in 42 of 55 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
The Aroon Indicator entered an Uptrend today. In 21 of 33 cases where BRIA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 16 of 17 cases where BRIA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BRIA as a result. In 42 of 42 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for BRIA turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 24 similar instances when the indicator turned negative. In 23 of the 24 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
BRIA moved below its 50-day moving average on November 04, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BRIA crossed bearishly below the 50-day moving average on November 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 3 of 3 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BRIA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.827) is normal, around the industry mean (1.858). P/E Ratio (11.000) is within average values for comparable stocks, (12.576). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.517). BRIA has a moderately high Dividend Yield (0.403) as compared to the industry average of (0.067). P/S Ratio (0.728) is also within normal values, averaging (0.652).
The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 70 (best 1 - 100 worst), indicating slightly worse than average price growth. BRIA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 80 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRIA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ApparelFootwearRetail